Literature DB >> 13917622

Inhibitory effect of Coxsackie virus, influenza virus, and interferon on Rous Sarcoma virus.

H STRANDSTROM, K SANDELIN, N OKER-BLOM.   

Abstract

Entities:  

Keywords:  COXIELLA/physiology; INFLUENZA VIRUSES/physiology; SARCOMA/virology

Mesh:

Substances:

Year:  1962        PMID: 13917622     DOI: 10.1016/0042-6822(62)90217-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  8 in total

1.  Interference between lymphocytic choriomeningitis virus and the leukemia-transmitting agent of leukemia L2C in guinea pigs.

Authors:  C W JUNGEBLUT; H KODZA
Journal:  Arch Gesamte Virusforsch       Date:  1963

2.  Comparative studies with the Zilber (Carr) strain of Rous sarcoma virus (Z-RSV). 3. Suppression of viral replication and focus formation by interferon in vitro.

Authors:  W H Traub; H R Morgan
Journal:  Arch Gesamte Virusforsch       Date:  1967

3.  Interfering action of myxovirus on polyoma virus in primary mouse embryo cell cultures.

Authors:  M Hatano; C Yoshie
Journal:  Arch Gesamte Virusforsch       Date:  1967

4.  The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3.

Authors:  G J Todaro; S Baron
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

5.  Effect of Coxsackie viruses of group A and B on Rous sarcoma virus.

Authors:  N Oker-Blom; P Leinikki
Journal:  Arch Gesamte Virusforsch       Date:  1965

6.  Interferon and host resistance to Rauscher virus-induced leukemia.

Authors:  L A Glasgow; S B Friedman
Journal:  J Virol       Date:  1969-02       Impact factor: 5.103

7.  Virus-induced sarcoma of mice: inhibition by a synthetic polyribonucleotide complex.

Authors:  P S Sarma; G Shiu; R H Neubauer; S Baron; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

8.  POSSIBLE ROLE OF INTERFERON IN DETERMINING THE ONCOGENIC EFFECT OF POLYOMA VIRUS VARIANTS.

Authors:  R M FRIEDMAN; A S RABSON
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.